Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
Clinical trial NCT01162122 · COMPLETED
Trial details
- NCT number
- NCT01162122
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-08-01
- Enrollment
- 7109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.